Foldax Inc. is pioneering advancements in heart valve technology with its TRIA™ heart valves, which are designed to provide long-lasting performance without compromising the quality of life for patients. Central to this innovation is the proprietary LifePolymer™ material, a non-animal-based polymer specifically formulated for heart valve applications. This material has shown promising pre-clinical results, demonstrating superior resistance to calcification and degradation over time, as well as biostability and biocompatibility. The TRIA™ valves are engineered using computer-generated designs that cater to the unique stresses experienced in aortic and mitral positions, ensuring optimal functionality and performance.

The manufacturing process at Foldax utilizes advanced robotic technology, allowing for highly precise and reproducible production of heart valves with minimal human intervention. This automated approach not only enhances efficiency but also reduces the labor-intensive aspects of traditional valve manufacturing. The combination of LifePolymer™ and robotic manufacturing positions Foldax at the forefront of transforming heart valve therapy, with the potential for future applications beyond heart valves. The TRIA™ heart valves are currently investigational and not available for sale, as clinical safety and efficacy have yet to be fully established.

United States

Our Vision:  To revolutionize the structural heart market with new material, design and manufacturing technology expanding patient access, improving product performance and significantly reducing costs.

Foldax Inc.

Company Details